Precog, Llc.
Clinical trials sponsored by Precog, Llc., explained in plain language.
-
New drug combo aims to boost immune attack on tough lung cancer
Disease control Recruiting nowThis study tests a new drug called ivonescimab, which helps the immune system fight cancer and blocks tumor blood vessel growth. About 60 adults with advanced small cell lung cancer who haven't had treatment will get ivonescimab plus standard chemo. The goal is to find the best d…
Phase: PHASE2 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Real-World data sought on common lung cancer drug combo
Knowledge-focused Recruiting nowThis study is not testing a new drug but watching how well standard treatments work for people with a specific type of lung cancer (EGFR-mutated NSCLC) in everyday medical practice. About 538 adults with advanced lung cancer will be followed to see how long they live without the …
Sponsor: PrECOG, LLC. • Aim: Knowledge-focused
Last updated May 15, 2026 11:52 UTC